Real-time Estimate
Cboe BZX
10:08:58 2024-03-28 am EDT
5-day change
1st Jan Change
8.895
USD
-5.97%
-4.91%
+48.83%
Sera Prognostics, Inc.(NasdaqGM:SERA) dropped from Russell 2500 Value Index
June 24, 2022 at 12:00 am EDT
Sera Prognostics, Inc.(NasdaqGM:SERA) dropped from Russell 2500 Value Index
Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing
Mar. 27
MT
Transcript : Sera Prognostics, Inc., 2023 Earnings Call, Mar 20, 2024
Mar. 20
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q4 Revenue $41,000
Mar. 20
MT
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 20
CI
Sector Update: Health Care Stocks Mixed Late Afternoon
Dec. 06
MT
Top Midday Gainers
Dec. 06
MT
Sector Update: Health Care Stocks Rise in Afternoon Trading
Dec. 06
MT
Sector Update: Health Care
Dec. 06
MT
Sera Prognostics Says Study of Preterm Birth Prevention Strategy Met Primary Endpoint Criteria; Shares Surge
Dec. 06
MT
Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success
Dec. 06
CI
Transcript : Sera Prognostics, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Nov. 08
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $42,000
Nov. 08
MT
Sera Prognostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 08
CI
Citigroup Adjusts Price Target on Sera Prognostics to $2.75 From $3.75, Maintains Neutral Rating
23-08-10
MT
Transcript : Sera Prognostics, Inc., Q2 2023 Earnings Call, Aug 09, 2023
23-08-09
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q2 Revenue $123,000
23-08-09
MT
Sera Prognostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-09
CI
Sera Prognostics, Inc. Announces the Resignation of Michael R. Foley, M.D., as Chief Medical Officer
23-07-31
CI
Sera Prognostics, Inc.(NasdaqGM:SERA) dropped from Russell Microcap Value Index
23-06-23
CI
Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell Microcap Growth Index
23-06-23
CI
Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell 3000E Growth Index
23-06-23
CI
Sera Prognostics, Inc.(NasdaqGM:SERA) dropped from Russell 3000E Value Index
23-06-23
CI
Sera Prognostics, Inc. Announces Resignation of Nadia Altomare from the Position of Chief Commercial Officer of the Company, Effective as of June 9, 2023
23-05-25
CI
Sera Prognostics, Inc. Announces Executive Changes
23-05-25
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sera Prognostics, Inc. is a women's health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop, and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. The Company's commercial product, the PreTRM test, is a blood-based biomarker test to accurately predict the risk of premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman carrying a single fetus during weeks 18 or 20 of gestation. Its biomarker pregnancy pipeline includes preeclampsia, molecular time-to-birth, gestational diabetes mellitus (GDM), fetal growth restriction, stillbirth, and postpartum depression.
More about the company
1st Jan change
Capi.
+48.83% 307M +20.37% 17.78B -13.94% 2.84B -16.27% 2.57B -34.46% 1.66B -10.06% 1.07B -14.18% 986M -7.37% 827M -14.76% 796M +11.20% 853M
Testing Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1